Recent updates

Browse recent updates. BMJ Best Practice is continuously updated to provide the latest evidence-based decision support.

  • 02 Feb 2023Global mpox outbreakTopic:Mpox (monkeypox)
  • 25 Jan 2023High rates of group A streptococcus infection in EnglandTopic:Tonsillitis
  • 25 Jan 2023High rates of group A streptococcus infection in EnglandTopic:Acute pharyngitis
  • 25 Jan 2023High rates of group A streptococcus infection in EnglandTopic:Sepsis in children
  • 25 Jan 2023High rates of group A streptococcus infection in EnglandTopic:Evaluation of fever in children
  • 13 Dec 2022Lecanemab slows cognitive decline in patients with early Alzheimer diseaseTopic:Alzheimer disease
  • 17 Nov 2022Healthcare providers advised to consider enterovirus D-68 and acute flaccid myelitisTopic:Enterovirus D-68
  • 02 Nov 2022Updated US guidelines based on findings from several clinical trials: some management strategies for spontaneous hemorrhagic stroke are not as effective as previously believedTopic:Hemorrhagic stroke
  • 01 Nov 2022Title: US Preventive Services Task Force recommends screening children 8 years and older for anxietyTopic:Generalized anxiety disorder
  • 26 Oct 2022US Preventive Services Task Force recommends screening children 8 and older for anxietyTopic:Social anxiety disorder
  • 26 Oct 2022US Preventive Services Task Force recommends screening children 8 and older for anxietyTopic:Phobias
  • 30 Sep 2022FDA approves tapinarof for adults with plaque psoriasisTopic:Psoriasis
  • 23 Sep 2022FDA and EMA approve baricitinib to treat severe alopecia areata in adultsTopic:Alopecia areata
  • 25 Aug 2022New US guidance includes updated recommendations on classification of heart failure, prevention, and treatment of symptomatic diseaseTopic:Acute heart failure
  • 09 Aug 2022Vaccine derived poliovirus (VDPV) detected in New York, London, and JerusalemTopic:Poliovirus infection
  • 05 Aug 2022Guidelines recommend measures to manage acute and chronic conditions during the COVID-19 pandemic: updatedTopic:Management of coexisting conditions in the context of COVID-19